Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technology Acquisition Corporation (TAC) was a special purpose acquisition company (SPAC) that served as a vehicle for bringing medical technology firms to the public markets. In 2005, the company completed a significant merger with MINRAD, a privately held innovator in acute care medical devices and pharmaceuticals. Following the acquisition, the combined entity operated under the MINRAD name, focusing on real-time image-guidance technologies and generic inhalation anesthetics. The company's portfolio included products for surgical interventions and proprietary drug delivery systems designed to reduce radiation exposure and improve procedural accuracy. TAC's primary role was the financial and structural facilitation of MINRAD's transition to a publicly traded company on the OTC Bulletin Board.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Acquisition.